# Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis

> **NCT03745417** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Guangdong Provincial Hospital of Traditional Chinese Medicine** · enrollment: 5 (estimated)

## Conditions studied

- Mesenchymal Stromal Cells
- Psoriasis
- Drug Effect
- Drug Toxicity

## Interventions

- **BIOLOGICAL:** Umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03745417
- **Lead sponsor:** Guangdong Provincial Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-31
- **Primary completion:** 2022-08-28
- **Final completion:** 2022-12-31
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2021-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745417, "Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT03745417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*